About
Acquisition, Development, Out-Licensing
Areas of Focus
Categories
Hawaii, Alaska, Puerto Rico
Team (8)
Bissan Musa
Bissan MusaNon-Executive Director
Ellipses Pharma
team_member
David Cook
David CookChief Financial Officer
Ellipses Pharma
team_member
Dr Fahad Khater
Dr Fahad KhaterNon-Executive Director
Ellipses Pharma
team_member
Martin Doorbar
Martin DoorbarChief Development Officer, Non Clinical
Ellipses Pharma
team_member
Nicky Pattrick. PhD
Nicky Pattrick. PhDChief Business Development Officer
Ellipses Pharma
team_member
Professor Hendrik-Tobias Arkenau
Professor Hendrik-Tobias ArkenauGlobal Head of Drug Development and Chief Medical Officer
Ellipses Pharma
executive
Clinical Trials (6)
View allTotal Trials
6
As Lead Sponsor
6
As Collaborator
0
Total Enrollment
619
By Phase
PHASE1/PHASE2: 4PHASE2: 2
By Status
RECRUITING: 3NOT_YET_RECRUITING: 1WITHDRAWN: 1COMPLETED: 1
Clinical Trials Pipeline6 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
Today
Hover over trial bars to see details
Recent Trials
NCT07030478Lead Sponsor
A Study to Evaluate the Safety and Tolerability of EP0089
PHASE1/PHASE2Not yet recruiting
190 participants
Started: Sep 30, 2025 · Completed: Jun 30, 2029
NCT05411679Lead Sponsor
EP0057 in Combination With Olaparib in Relapsed Advanced Gastric Cancer and Small Cell Lung Cancer
PHASE2Withdrawn
Started: Apr 30, 2023 · Completed: Dec 31, 2024
NCT05573126Lead Sponsor
Phase 1/2 Study to Evaluate Vosilasarm (EP0062) as Monotherapy and in Combination in Patients With Advanced or Metastatic AR+/HER-2-/ER+ Breast Cancer
PHASE1/PHASE2Recruiting
60 participants
Started: Jan 11, 2023 · Completed: Nov 30, 2026
NCT05443126Lead Sponsor
A Study of EP0031 in Patients With Advanced RET-altered Malignancies
PHASE1/PHASE2Recruiting
265 participants
Started: Sep 30, 2022 · Completed: Jun 30, 2027
NCT04669002Lead Sponsor
EP0057 in Combination With Olaparib in Advanced Ovarian Cancer
PHASE2Completed
34 participants
Started: Dec 14, 2020 · Completed: May 5, 2023
Locations (1)
Headquarters
London, UK
Map
Loading map...